GSK's COPD Triple Combo To Challenge Chiesi's Trimbow In EU

 
• By Lucie Ellis-Taitt

GSK's closed triple combination for COPD, Trelegy, is expected to get a green light for approval in Europe on Friday – but the product will be fighting for market share against Chiesi's triple combination Trimbow, which has a head start.

Easy as 1, 2, 3
The competition is about to heat up for triple COPD therapies in Europe • Source: Shutterstock

More from New Products

More from Scrip